Recruiting studies: Developmental And Epileptic Encephalopathy Dee

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

SLC6A1-NDD Prospective Longitudinal Natural History Study
Phase N/A · 3 location(s) · UCB Biopharma SRL · NCT07531511 A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety
Phase 3 · 10 location(s) · Praxis Precision Medicines · NCT07019922 A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of Relutrigine
Phase 3 · 11 location(s) · Praxis Precision Medicines · NCT07010471 A Clinical Trial of PRAX-222 in Pediatric Participants With Early Onset SCN2A Developmental and Epileptic Encephalopathy
Phase 1/Phase 2 · 3 location(s) · Praxis Precision Medicines · NCT05737784 Developmental and Epileptic Encephalopathy of Genetic Etiology: Natural History Through Reuse of Clinical Data
Phase N/A · 23 location(s) · Imagine Institute · NCT06380192 Genetic Developmental and Epileptic Encephalopathy Natural History Study for Clinical Trial Readiness
Phase N/A · 1 location(s) · Weill Medical College of Cornell University · NCT07413211 A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndro
Phase 1/Phase 2 · 14 location(s) · Encoded Therapeutics · NCT05419492 BMB-101 in Absence Epilepsy and DEE
Phase 2 · 5 location(s) · Bright Minds Biosciences Pty Ltd · NCT06401538

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.